(Institución)/></a>
				</td>
				<td class= (Institución)
   (Nuevo usuario)
Ayuda  | Contacto  |  Castellano English  
 

Dadun > Depósito Académico > CIMA (Centro de Investigación Médica Aplicada) > Área de Terapia génica y Hepatología > Virología > DA - CIMA - Terapia génica y Hepatología - Virología - Artículos de revista >

Cardiotrophin-1 promotes a high survival rate in rabbits with lethal fulminant hepatitis of viral origin
Autor(es) : Tuñon, M.J. (María Jesús)
San-Miguel, B. (Beatriz)
Crespo, I. (Irene)
Riezu-Boj, J.I. (José Ignacio)
Larrea, E. (Esther)
Alvarez, M. (Marcelino)
Gonzalez, I. (Iranzu)
Bustos, M. (Matilde)
Gonzalez-Gallego, J. (Javier)
Prieto, J. (Jesús)
Palabras clave : Caliciviridae infections/veterinary
Cytokines/administration and dosage
Hemorrhagic disease virus, rabbit/pathogenicity
Hepatitis, viral, animal/drug therapy
Hepatitis, viral, animal/mortality
Immunologic factors/administration and dosage
Fecha incorporación: 2011
Editorial : American Society for Microbiology
Versión del editor: http://jvi.asm.org/content/85/24/13124
ISSN: 1098-5514
Cita: Tunon MJ, San Miguel B, Crespo I, Riezu-Boj JI, Larrea E, Alvarez M, et al. Cardiotrophin-1 promotes a high survival rate in rabbits with lethal fulminant hepatitis of viral origin. J Virol 2011 Dec;85(24):13124-13132.
Resumen
Rabbit hemorrhagic disease virus (RHDV) causes lethal fulminant hepatitis closely resembling acute liver failure (ALF) in humans. In this study, we investigated whether cardiotrophin-1 (CT-1), a cytokine with hepatoprotective properties, could attenuate liver damage and prolong survival in virus-induced ALF. Twenty-four rabbits were infected with 2 × 10(4) hemagglutination units of RHDV. Twelve received five doses of CT-1 (100 μg/kg) starting at 12 h postinfection (hpi) (the first three doses every 6 h and then two additional doses at 48 and 72 hpi), while the rest received saline. The animals were analyzed for survival, serum biochemistry, and viral load. Another cohort (n = 22) was infected and treated similarly, but animals were sacrificed at 30 and 36 hpi to analyze liver histology, viral load, and the expression of factors implicated in liver damage and repair. All infected rabbits that received saline died by 60 hpi, while 67% of the CT-1-treated animals survived until the end of the study. Treated animals showed improved liver function and histology, while the viral loads were similar. In the livers of CT-1-treated rabbits we observed reduction of oxidative stress, diminished PARP1/2 and JNK activation, and decreased inflammatory reaction, as reflected by reduced expression of tumor necrosis factor alpha, interleukin-1β, Toll-like receptor 4, VCAM-1, and MMP-9. In addition, CT-1-treated rabbits exhibited marked upregulation of TIMP-1 and increased expression of cytoprotective and proregenerative growth factors, including platelet-derived growth factor B, epidermal growth factor, platelet-derived growth factor receptor β, and c-Met. In conclusion, in a lethal form of acute viral hepatitis, CT-1 increases animal survival by attenuating inflammation and activating cytoprotective mechanisms, thus representing a promising therapy for ALF of viral origin.
Enlace permanente: http://hdl.handle.net/10171/23051
Aparece en las colecciones: DA - CIMA - Terapia génica y Hepatología - Inmunología clínica - Artículos de revista
DA - CUN - Hepatología - Artículos de revista
DA - CIMA - Terapia génica y Hepatología - Virología - Artículos de revista

Ficheros en este registro:
Fichero:  JVirol2011_852413124.pdf
Descripción: 
Tamaño:  2,52 MB
Formato:  Adobe PDF
 Visualizar / Abrir 

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.